CTCF and neoplasm: Moreover, given the extensive characterization of CTCF as a tumor suppressor gene (120,136,141–143), its frequent mutation in cancer (133,134,136) and loss- or gain-of-function phenotypes (135), causal links between CTCF-mediated aberrant AS and cancer are likely to emerge (144,145).